HER2 Positive CTC in Advanced Gastric Cancer — AGC-HER2CTC  

HER2 Positive Advanced Gastric Cancer Clinical Trial

Official title: Clinical Significance of HER2 Positive Circulating Tumor Cells(CTCs) in the Peripheral Blood of Patients With Advanced Gastric Cancer

Status Not yet recruiting

Clinical Trial Summary

To identify the correlation of HER2 expression in tissue and peripheral CTC. to identify the HER2 expression in CTCs with clinical prognosis in advanced/metastatic gastric cancer.

Confirm the presence of CTCs are sensitive for monitoring response to chemotherapy.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Bio-equivalence Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science

Related Conditions & MeSH terms

• HER2 Positive Advanced Gastric Cancer
• Stomach Neoplasms

• NCT number: NCT01847794
• Study type: Interventional
• Source: Peking University
• Contact: lin shen, MD. PhD
• Phone: (86)10-88196175
• Email: lin100@medmail.com.cn
• Status: Not yet recruiting
• Phase: N/A
• Start date: June 2013
• Completion date: June 2016